Macrogenics (MGNX) Misses Q2 EPS by 20c

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.66), $0.20 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $30.03 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Sun Communities names Ileana McAlary as general counsel and EVP